Analyst Profile

Followed by 32 followers
.
Steve Baxter

Steve Baxter

Wells Fargo
Wall Street Analyst
#6,006 out of 8,141 Wall Street Analysts
#17,594 out of 24,284 experts

Success Rate

57%
36 out of 63 transactions made a profit

Average Return

-2.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Steve Baxter's trades since 2019 and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of -2.2% per rating.

Stock Rating Distribution

94Ratings
58.51% Buy
29.79% Hold
11.70% Sell
Distribution of Steve Baxter's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Charles River Laboratories Intl
(CRL)
Rating:Buy
Date:Feb 18, 2020 - Feb 18, 2021
Return:+66.20%
The most profitable rating made by Steve Baxter

Steve Baxter's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Syneos Health
Nov 13, 2019
Hold
Reiterated
$57.00
(69.69% Upside)
1Ratings
0.00%
IQVIA Holdings
Nov 14, 2019
Buy
Upgraded
1Ratings
100%
+19.30%
Charles River Labs
Feb 18, 2020
Buy
Upgraded
$203.00
(-14.39% Downside)
1Ratings
100%
+66.20%
PRAH
PRA Health Sciences
Apr 13, 2020
Hold
Downgraded
2Ratings
0%
-19.80%
Quest Diagnostics
Apr 27, 2020
Hold
Upgraded
$116.00
(-22.18% Downside)
1Ratings
0.00%
Medpace Holdings
May 13, 2020
Hold
Downgraded
$91.00
(-57.21% Downside)
2Ratings
100%
+7.00%
McKesson
May 22, 2020
Buy
Upgraded
$184.00
(-51.62% Downside)
2Ratings
100%
+37.00%
Cardinal Health
Jan 08, 2021
Hold
Upgraded
$58.00
(-26.08% Downside)
1Ratings
0.00%
Laboratory
Jan 11, 2021
Hold
Downgraded
$235.00
(-1.41% Downside)
6Ratings
67%
+6.40%
American Well
Feb 28, 2022
Hold
Reiterated
$4.00
(17.30% Upside)
3Ratings
0.00%
List of latest recommendations made by Steve Baxter. Click to expand and see Steve Baxter's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >